More News
HEALTHCARE | Staff Reporter, China
view(s)

China dominates APAC's interventional cardiology devices market

Diseases in the circulatory system are amongst the top causes of death in the country.

China is the largest market for interventional cardiology devices used for treating heart ailments in the Asia Pacific region in 2020 and it is expected to hold that position through 2025, a report from GlobalData revealed.

The interventional cardiology devices market in China is expected to grow at a compound annual growth rate of 4.7% between 2015 and 2025. There is a huge potential for the interventional cardiology devices market in China as cardiovascular diseases are the major cause of morbidity and mortality in the nation, the report stated.

This was attributed to a rise in the geriatric population in China as the country’s population is aging at a faster rate than almost all other countries in the Asia-Pacific region.

However, challenges in the market such as high manufacturing cost, lack of awareness, and insufficient medical resources in rural areas should be addressed to further drive the market, GlobalData’s medical devices analyst Shweta Yadav commented.
 

Do you know more about this story? Contact us anonymously through this link.

Click here to learn about advertising, content sponsorship, events & rountables, custom media solutions, whitepaper writing, sales leads or eDM opportunities with us.

To get a media kit and information on advertising or sponsoring click here.